Sirin Korulu

Sirin Korulu

Auto-generated profile, based on publicly available information

Sirin Korulu

Division of Neuropsychopharmacology, Institute of Chemistry, University of Tartu, Tartu, Estonia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
WYWenqian Yu
Wenqian Yu
LQLiang Qiang
Liang Qiang
JSJoanna M. Solowska
Joanna M. Solowska
AKArzu Karabay
Arzu Karabay
SKSirin Korulu
Sirin Korulu
PBPeter W. Baas
Peter W. Baas
Neurons express two different microtubule-severing proteins, namely P60-katanin and spastin. Here, we performed studies on cultured neurons to ascertain whether these two proteins participate differently in axonal branch formation. P60-katanin is more highly expressed in the neuron, but spastin is more concentrated at sites of branch formation. Overexpression of spastin dramatically enhances the formation of branches, whereas overexpression of P60-katanin does not. The excess spastin results in large numbers of short microtubules, whereas the excess P60-katanin results in short microtubules intermingled with longer microtubules. We hypothesized that these different microtubule-severing patterns may be due to the presence of molecules such as tau on the microtubules that more strongly shield them from being severed by P60-katanin than by spastin. Consistent with this hypothesis, we found that axons depleted of tau show a greater propensity to branch, and that this is true whether or not the axons are also depleted of spastin. We propose that there are two modes by which microtubule severing is orchestrated during axonal branch formation, one based on the local concentration of spastin at branch sites and the other based on local detachment from microtubules of molecules such as tau that regulate the severing properties of P60-katanin.

1 February 2015 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
AYAysegul Yildiz
Aysegul Yildiz
SKSirin Korulu
Sirin Korulu
AKArzu Karabay
Arzu Karabay
Calpains are calcium-dependent proteolytic enzymes that have deleterious effects on neurons upon their pathological over-activation. According to the results of numerous studies to date, there is no doubt that abnormal calpain activation triggers activation and progression of apoptotic processes in neurodegeneration, leading to neuronal death. Thus, it is very crucial to unravel all the aspects of calpain-mediated neurodegeneration in order to protect neurons through eliminating or at least minimizing its lethal effects. Protecting neurons against calpain-activated apoptosis basically requires developing effective, reliable, and most importantly, therapeutically applicable approaches to succeed. From this aspect, the most significant studies focusing on preventing calpain-mediated neurodegeneration include blocking the N-methyl-d-aspartate (NMDA)-type glutamate receptor activities, which are closely related to calpain activation; directly inhibiting calpain itself via intrinsic or synthetic calpain inhibitors, or inhibiting its downstream processes; and utilizing the neuroprotectant steroid hormone estrogen and its receptors. In this review, the most remarkable neuroprotective strategies for calpain-mediated neurodegeneration are categorized and summarized with respect to their advantages and disadvantages over one another, in terms of their efficiency and applicability as a therapeutic regimen in the treatment of neurodegenerative diseases.

1 January 2009 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
ODOzlem Demir
Ozlem Demir
SKSirin Korulu
Sirin Korulu
AYAysegul Yildiz
Aysegul Yildiz
AKArzu Karabay
Arzu Karabay
IKIsil Kurnaz
Isil Kurnaz

15 March 2013 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
SKSirin Korulu
Sirin Korulu
AYAysegul Yildiz
Aysegul Yildiz
MYMeral Yuksel
Meral Yuksel
AKArzu Karabay
Arzu Karabay

12 April 2011 in Neuroscience Letters
Verified
Journal Article
Closed access
YNYesim Negis
Yesim Negis
AYAysegul Yildiz
Aysegul Yildiz
SKSirin Korulu
Sirin Korulu
AKArzu Karabay
Arzu Karabay

24 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ESEce Selçuk
Ece Selçuk
KKKoray Kırımtay
Koray Kırımtay
DCDerya Canbaz
Derya Canbaz
GCGüher Işık Cesur
Güher Işık Cesur
SKSirin Korulu
Sirin Korulu
AKArzu Karabay
Arzu Karabay
Katanin is an ATPase family member protein that participates in microtubule severing. It has heterodimeric structure consisting of 60 kDa (katanin-p60) and 80 kDa (katanin-p80) subunits encoded by KATNA1 and KATNB1 genes, respectively. Katanin-p60 has the enzymatic activity for microtubule severing, whereas katanin-p80 consists of multiple domains with different functions such as targeting katanin-p60 to the centrosome, augmenting microtubule severing by katanin-p60, and even suppressing microtubule severing. Despite the various important functions of katanin-p80, its transcriptional regulation has not been studied yet. Elk1 transcription factor has been shown to interact with microtubules and regulate the transcription of another microtubule severing protein, spastin. In spite of katanin’s importance, and structural and functional similarities to spastin, there is no study on the transcriptional regulation of katanin yet. In this study, we aimed to characterize KATNB1 promoter and analyze the effects of Elk1 on katanin-p80 expression. We identified a 518- bp TATA-less promoter including a critical CpG island and GC boxes as an optimal promoter, and sequential deletion of CpG island and the GC elements gradually decreased the KATNB1 promoter activity. In addition, we showed Elk1 binding on the KATNB1 promoter by EMSA. We found that Elk1 activated KATNB1 promoter, and increased both mRNA and protein levels of katanin-p80 in SH-SY5Y cells. On the other hand, KCl treatment increasing SUMOylation decreased KATNB1 promoter activity. Since microtubule severing is an important cellular mechanism of which malfunctions result in serious diseases such as spastic paraplegia, Alzheimer’s disease and cell cycle related disorders, identification of KATNB1 transcriptional regulation is crucial in understanding the coordination of microtubule severing activity by different proteins in the cells.